Você procurou por: radjuimmunopreċipitazzjoni (Maltês - Inglês)

maż-żmien, il-biċċa l-kbira ta’ pazjenti seropożittivi fil-provi kliniċi wrew jew xejra l-isfel fit-titri (fuq bażi ta’ tnaqqis ta’≥ 4 darbiet fit-titru mill-kejl l-aktar għoli sa l-aħħar kejl) (40% tal-pazjenti), ittolerizzaw (l-ebda antikorpi intraċċati kkonfermati permezz ta’ 2 assaġġi ta’ radjuimmunopreċipitazzjoni (rip) konsekuttivi) (14% tal-pazjenti) jew urew livellar (35% tal-pazjenti).
over time, the majority of seropositive patients in clinical trials demonstrated either a downward trend in titers (based on a ≥ 4-fold reduction in titer from the peak measurement to the last measurement) (40% of the patients), tolerised (no detectable antibodies confirmed by 2 consecutive radioimmuno- precipitation (rip) assays) (14% of the patients) or demonstrated a plateau (35% of the patients).